Melrose FutureLab Inflammation Modulator 60 Capsules

Melrose FutureLab Inflammation modulator helps to relieve symptoms of mild arthritis and reduces mild joint aches and pains. This is a premium quality formula featuring Meriva® Curcuma longa phospholipid complex, a patented and clinically trialled form of curcumin. Melrose FutureLab Inflammation modulator also contains Palmitoylethanolamide (PEA), a fatty acid that belongs to the family of endocannabinoid. The formula leverages the Phytosomal® active ingredient delivery technology to enhance absorption rates and optimise bioavailability within the body.

• Anti-inflammatory • Decrease mild joint aches and pains • Reduce symptoms of mild arthritis and mild osteoarthritis

Adults - Take two capsule with water, daily, or as directed by your health professional Warnings: Adults only. The medicine may interact with other prescription analgesic medicines, please consult your healthcare practitioner before use. Not to be used for more than 21 consecutive days. In very rare cases, Curcuma species may harm the liver. Stop use and see a doctor if you have yellowing skin/eyes or unusual: fatigue, nausea, appetite loss, abdominal pain, dark urine, or itching. If symptoms persist, talk to your health professional. Store below 25°C away from direct sunlight. Do not use if tamper evident seals are broken or missing.

Melrose creates products that will genuinely improve your health, and they make sure they taste great while you’re at it. Over the last 40 years, Melrose has grown from a little home office to one of Australia’s leading and most trusted health brands. Today, Melrose group has over 100 employees, manufacturing in Melbourne and is still proudly Australian-owned.

Meriva® Curcumin Phytosome® 500mg containing Curcuma longa rhizome ext. dry conc. 100mg derived from Curcuma longa fresh rhizome 16.5g std. to contain curcuminoids 90mg, Palmidrol (PEA) 150mg